Suppr超能文献

2023 年 EFLM 欧洲尿液分析指南。

The EFLM European Urinalysis Guideline 2023.

机构信息

Department of Clinical Chemistry, University of Helsinki, Helsinki, Finland.

HUSLAB, HUS Diagnostic Center, Hospital District of Helsinki and Uusimaa, 00014 Helsinki, Finland.

出版信息

Clin Chem Lab Med. 2024 Jun 5;62(9):1653-1786. doi: 10.1515/cclm-2024-0070. Print 2024 Aug 27.

Abstract

BACKGROUND

The EFLM Task and Finish Group Urinalysis has updated the ECLM European Urinalysis Guidelines (2000) on urinalysis and urine bacterial culture, to improve accuracy of these examinations in European clinical laboratories, and to support diagnostic industry to develop new technologies.

RECOMMENDATIONS

Graded recommendations were built in the following areas.

MEDICAL NEEDS AND TEST REQUISITION

Strategies of urine testing are described to patients with complicated or uncomplicated urinary tract infection (UTI), and high or low-risk to kidney disease.

SPECIMEN COLLECTION

Patient preparation, and urine collection are supported with two quality indicators: contamination rate (cultures), and density of urine (chemistry, particles).

CHEMISTRY

Measurements of both urine albumin and α1-microglobulin are recommended for sensitive detection of kidney disease in high-risk patients. Performance specifications are given for urine protein measurements and quality control of multiproperty strip tests.

PARTICLES

Procedures for microscopy are reviewed for diagnostic urine particles, including urine bacteria. Technologies in automated particle counting and visual microscopy are updated with advice how to verify new instruments with the reference microscopy.

BACTERIOLOGY

Chromogenic agar is recommended as primary medium in urine cultures. Limits of significant growth are reviewed, with an optimised workflow for routine specimens, using leukocyturia to reduce less important antimicrobial susceptibility testing. Automation in bacteriology is encouraged to shorten turn-around times. Matrix assisted laser desorption ionization time-of-flight mass spectrometry is applicable for rapid identification of uropathogens. and are taken into the list of uropathogens. A reference examination procedure was developed for urine bacterial cultures.

摘要

背景

EFLM 任务和完成小组尿液分析更新了 ECLM 欧洲尿液分析指南(2000 年),以提高欧洲临床实验室这些检查的准确性,并支持诊断行业开发新技术。

建议

在以下领域建立了分级建议。

医疗需求和测试要求

向患有复杂或简单尿路感染(UTI)以及患有肾脏疾病高或低风险的患者描述了尿液测试策略。

标本采集

患者准备和尿液采集有两个质量指标支持:污染率(培养物)和尿液密度(化学,颗粒)。

化学

建议对高危患者的肾脏疾病进行敏感检测,同时测量尿液白蛋白和α1-微球蛋白。给出了尿液蛋白测量和多属性条带测试质量控制的性能规格。

颗粒

对诊断尿液颗粒(包括尿液细菌)的显微镜检查程序进行了审查。更新了自动化颗粒计数和目视显微镜技术,并提供了如何使用参考显微镜验证新仪器的建议。

细菌学

推荐显色琼脂作为尿液培养的主要培养基。审查了重要生长的界限,并优化了常规标本的工作流程,使用白细胞尿减少不太重要的抗菌药物敏感性测试。鼓励细菌学自动化以缩短周转时间。基质辅助激光解吸电离飞行时间质谱可用于快速鉴定尿路病原体。 和 被列入尿路病原体清单。为尿液细菌培养制定了参考检查程序。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验